Zheng W - Search Results

1

Advances in drug development for targeted therapies for glioblastoma.

Yan G, Wang Y, Chen J, Zheng W, Liu C, Chen S, Wang L, Luo J, Li Z. Yan G, et al. Among authors: zheng w. Med Res Rev. 2020 Sep;40(5):1950-1972. doi: 10.1002/med.21676. Epub 2020 May 23. Med Res Rev. 2020. PMID: 32445532 Review.

2

Lost region in amyloid precursor protein (APP) through TALEN-mediated genome editing alters mitochondrial morphology.

Wang Y, Wu F, Pan H, Zheng W, Feng C, Wang Y, Deng Z, Wang L, Luo J, Chen S. Wang Y, et al. Among authors: zheng w. Sci Rep. 2016 Feb 29;6:22244. doi: 10.1038/srep22244. Sci Rep. 2016. PMID: 26924205 Free PMC article.

3

C9orf72 regulates the unfolded protein response and stress granule formation by interacting with eIF2α.

Zheng W, Wang K, Wu Y, Yan G, Zhang C, Li Z, Wang L, Chen S. Zheng W, et al. Theranostics. 2022 Oct 17;12(17):7289-7306. doi: 10.7150/thno.76138. eCollection 2022. Theranostics. 2022. PMID: 36438488 Free PMC article.

4

C9orf72 controls hepatic lipid metabolism by regulating SREBP1 transport.

Wu Y, Zheng W, Xu G, Zhu L, Li Z, Chen J, Wang L, Chen S. Wu Y, et al. Among authors: zheng w. Cell Death Differ. 2024 Aug;31(8):1070-1084. doi: 10.1038/s41418-024-01312-7. Epub 2024 May 30. Cell Death Differ. 2024. PMID: 38816580

5

SP1, MYC, CTNNB1, CREB1, JUN genes as potential therapy targets for neuropathic pain of brain.

Yan XT, Xu Y, Cheng XL, He XH, Wang Y, Zheng WZ, Zhao Y, Chen H, Wang YL. Yan XT, et al. J Cell Physiol. 2019 May;234(5):6688-6695. doi: 10.1002/jcp.27413. Epub 2018 Nov 27. J Cell Physiol. 2019. PMID: 30478830

6

Inhibition of miR-200b/miR-429 contributes to neuropathic pain development through targeting zinc finger E box binding protein-1.

Yan XT, Zhao Y, Cheng XL, He XH, Wang Y, Zheng WZ, Chen H, Wang YL. Yan XT, et al. J Cell Physiol. 2018 Jun;233(6):4815-4824. doi: 10.1002/jcp.26284. Epub 2018 Jan 15. J Cell Physiol. 2018. PMID: 29150958

7

XIST accelerates neuropathic pain progression through regulation of miR-150 and ZEB1 in CCI rat models.

Yan XT, Lu JM, Wang Y, Cheng XL, He XH, Zheng WZ, Chen H, Wang YL. Yan XT, et al. J Cell Physiol. 2018 Aug;233(8):6098-6106. doi: 10.1002/jcp.26453. Epub 2018 Mar 6. J Cell Physiol. 2018. PMID: 29323698

8

Retraction notice to "LncRNA MALAT1 regulates sepsis-induced cardiac inflammation and dysfunction via interaction with miR-125b and p38 MAPK/NFκB" [Int. Immunopharmacol. 55 (2018) 69-76].

Chen H, Wang X, Yan X, Cheng X, He X, Zheng W. Chen H, et al. Among authors: zheng w. Int Immunopharmacol. 2021 Aug;97:107800. doi: 10.1016/j.intimp.2021.107800. Epub 2021 Jun 28. Int Immunopharmacol. 2021. PMID: 34210636 No abstract available.

9

HO-1 Overexpressed Mesenchymal Stem Cells Ameliorate Sepsis-Associated Acute Kidney Injury by Activating JAK/stat3 Pathway.

Yan X, Cheng X, He X, Zheng W, Yuan X, Chen H. Yan X, et al. Among authors: zheng w. Cell Mol Bioeng. 2018 Sep 6;11(6):509-518. doi: 10.1007/s12195-018-0540-0. eCollection 2018 Dec. Cell Mol Bioeng. 2018. PMID: 31719896 Free PMC article.

10

RETRACTED: LncRNA MALAT1 regulates sepsis-induced cardiac inflammation and dysfunction via interaction with miR-125b and p38 MAPK/NFκB.

Chen H, Wang X, Yan X, Cheng X, He X, Zheng W. Chen H, et al. Among authors: zheng w. Int Immunopharmacol. 2018 Feb;55:69-76. doi: 10.1016/j.intimp.2017.11.038. Epub 2017 Dec 22. Int Immunopharmacol. 2018. Retraction in: Int Immunopharmacol. 2021 Aug;97:107800. doi: 10.1016/j.intimp.2021.107800 PMID: 29227823 Retracted.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

14,034 results

Search Page

Filters